AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...

The boss of AstraZeneca Plc said he does not believe the UK is the worst place to invest, striking a conciliatory tone just ...

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...

Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” ...

The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In late November 2023 AstraZeneca’s chief executive Pascal Soriot flew from Sydney to London to deliver a ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed earlier this week, saying Labour failed to match the previous government’s ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision. The boss of drugmaker AstraZeneca has said he was ‘very disappointed’ with the firm’s ...

Pascal Soriot, chief executive officer of the UK’s biggest drugmaker, was responding to reports that the company’s relationship with the new Labour government has soured, with Britain being ...